Newly Found Stem Cell State Closer to Transitional Precipice – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Newly Found Stem Cell State Closer to Transitional Precipice
Genetic Engineering & Biotechnology News Embryonic lineages may emerge from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), which are generally considered pluripotent, not totipotent, because they have not been thought capable of giving rise to extraembryonic cell … |
|
ReNeuron stem cell therapy shows long-term promise for stroke
Reuters The procedure involves injecting ReNeuron’s neural stem cells into patients’ brains to repair areas damaged by stroke, thereby improving both mental and physical function. The Phase I trial is designed primarily to test whether the experimental … |
|
ReNeuron stem cell therapy shows long-term promise for stroke
Reuters The procedure involves injecting ReNeuron’s neural stem cells into patients’ brains to repair areas damaged by stroke, thereby improving both mental and physical function. The Phase I trial is designed primarily to test whether the experimental … |
|
Stem cell research proves beneficial and controversial
KTAL It’s a debate that puts many people’s religious beliefs at odds with science. Medical breakthroughs have allowed doctors to use human stem cells to treat chronic diseases with incredible results, but even patients who benefit have reservations about … |
|
Stem cell research proves beneficial and controversial
KTAL It’s a debate that puts many people’s religious beliefs at odds with science. Medical breakthroughs have allowed doctors to use human stem cells to treat chronic diseases with incredible results, but even patients who benefit have reservations about … |
Channel News Asia |
Athersys tanks as its stem cell therapy flunks a Phase II stroke trial
FierceBiotech Athersys’ ($ATHX) in-development stem cell treatment failed to beat placebo in a Phase II trial on stroke patients, demolishing the company’s value as management digs for a positive spin. The company’s treatment, called MultiStem, is meant to reverse … Athersys’ stroke clinical trial yields disappointing resultsCrain’s Cleveland Business |